Qube Research & Technologies (QRT)
RCUS icon

Qube Research & Technologies (QRT)’s Arcus Biosciences RCUS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,556
Closed -$833K – 3962
2026
Q1 		$833K Buy
+38,556
New +$833K ﹤0.01% 2567
2025
Q3 		– Sell
-84,049
Closed -$684K – 3880
2025
Q2 		$684K Buy
+84,049
New +$718K ﹤0.01% 2600
2021
Q2 		– Sell
-23,433
Closed -$658K – 2715
2021
Q1 		$658K Buy
23,433
+12,726
+119% +$443K 0.01% 1025
2020
Q4 		$278K Sell
10,707
-421
-4% -$10.2K ﹤0.01% 1383
2020
Q3 		$191K Sell
11,128
-19,869
-64% -$444K ﹤0.01% 1407
2020
Q2 		$767K Buy
+30,997
New +$837K 0.01% 955

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RCUS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 38,556 shares — an estimated $833K sold.

Qube Research & Technologies (QRT) first reported a position in RCUS in Q2 2020 and held it in 6 quarters. The position peaked at $833K in Q1 2026. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 38,556 Arcus Biosciences shares in Q2 2026, an estimated $833K.
  • Qube Research & Technologies (QRT) first reported a position in Arcus Biosciences in Q2 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Arcus Biosciences position peaked at $833K in Q1 2026.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.